AU6678894A - Diagnostic probes and their use in detecting human chromosomal abnormalities - Google Patents

Diagnostic probes and their use in detecting human chromosomal abnormalities

Info

Publication number
AU6678894A
AU6678894A AU66788/94A AU6678894A AU6678894A AU 6678894 A AU6678894 A AU 6678894A AU 66788/94 A AU66788/94 A AU 66788/94A AU 6678894 A AU6678894 A AU 6678894A AU 6678894 A AU6678894 A AU 6678894A
Authority
AU
Australia
Prior art keywords
detecting human
chromosomal abnormalities
diagnostic probes
human chromosomal
probes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU66788/94A
Inventor
Patrizia Carotenuto
Carlo Maria Croce
Masaharu Isobe
Maria Grazia Narducci
Giandomenico Russo
Laura Virgilio
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Raggio-Italgene SpA
Original Assignee
Raggio-Italgene SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Raggio-Italgene SpA filed Critical Raggio-Italgene SpA
Publication of AU6678894A publication Critical patent/AU6678894A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU66788/94A 1993-04-15 1994-04-15 Diagnostic probes and their use in detecting human chromosomal abnormalities Abandoned AU6678894A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9307754 1993-04-15
GB939307754A GB9307754D0 (en) 1993-04-15 1993-04-15 Diagnostic probes and therapeutic products
PCT/EP1994/001183 WO1994024308A1 (en) 1993-04-15 1994-04-15 Diagnostic probes and their use in detecting human chromosomal abnormalities

Publications (1)

Publication Number Publication Date
AU6678894A true AU6678894A (en) 1994-11-08

Family

ID=10733850

Family Applications (1)

Application Number Title Priority Date Filing Date
AU66788/94A Abandoned AU6678894A (en) 1993-04-15 1994-04-15 Diagnostic probes and their use in detecting human chromosomal abnormalities

Country Status (3)

Country Link
AU (1) AU6678894A (en)
GB (1) GB9307754D0 (en)
WO (1) WO1994024308A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0859860A1 (en) * 1995-10-23 1998-08-26 Imperial Cancer Research Technology Limited Diagnosis of susceptibility to cancer and treatment thereof
US6287854B1 (en) 1996-10-22 2001-09-11 Imperial Cancer Research Technology Limited Diagnosis of susceptibility to cancer and treatment thereof
EP0878552A1 (en) * 1997-05-13 1998-11-18 Erasmus Universiteit Rotterdam Molecular detection of chromosome aberrations
CA2367906A1 (en) * 1999-03-15 2000-09-21 Thomas Jefferson University Tcl-1b gene and protein and related methods and compositions
EP2653561B1 (en) 2007-08-03 2016-03-02 The Ohio State University Research Foundation Ultraconserved regions encoding ncRNAs
WO2009055773A2 (en) 2007-10-26 2009-04-30 The Ohio State University Research Foundation Methods for identifying fragile histidine triad (fhit) interaction and uses thereof
EP2307028B1 (en) 2008-06-11 2013-10-02 The Government of the United States of America as represented by The Secretary of the Department of Health and Human Services Use of mir-26 family as a predictive marker of hepatocellular carcinoma and responsiveness to therapy
CN102803511A (en) 2009-11-23 2012-11-28 俄亥俄州立大学 Materials and methods useful for affecting tumor cell growth, migration and invasion
JP5931897B2 (en) 2010-11-12 2016-06-08 ジ・オハイオ・ステイト・ユニバーシティ・リサーチ・ファウンデイションThe Ohio State University Research Foundation Materials and methods associated with microRNA-21, mismatch repair and colorectal cancer
US10758619B2 (en) 2010-11-15 2020-09-01 The Ohio State University Controlled release mucoadhesive systems
AU2012323924A1 (en) 2011-10-14 2014-05-29 The Ohio State University Methods and materials related to ovarian cancer
WO2013090556A1 (en) 2011-12-13 2013-06-20 The Ohio State University Methods and compositions related to mir-21 and mir-29a, exosome inhibition, and cancer metastasis
WO2013110053A1 (en) 2012-01-20 2013-07-25 The Ohio State University Breast cancer biomarker signatures for invasiveness and prognosis
WO2016168176A1 (en) 2015-04-13 2016-10-20 Cook Medical Technologies Llc Axial lock and release stent deployment system

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5932790A (en) * 1989-07-03 1991-01-17 Temple University Tcl-5 gene rearrangement involved in t-cell leukemia and melanoma

Also Published As

Publication number Publication date
WO1994024308A1 (en) 1994-10-27
GB9307754D0 (en) 1993-06-02

Similar Documents

Publication Publication Date Title
GB2248688B (en) Diagnostic kit for diagnosing and distinguishing chest pain in early onset thereof
GB2295905B (en) Device for use in visual field examination
GB9306637D0 (en) Electrosurgery monitor and appartus
AU3173793A (en) Display device in medical examination and treatment system
EP0862378A4 (en) Pressure measurement in blood treatment
AU1614895A (en) Endoscopic portal for use in endoscopic procedures and methods therefor
TW480992U (en) Physiological information measuring device and wrist-type pulse measuring device
ZA973886B (en) A system for measuring and indicating changes in the resistance of a living body
AU3897595A (en) Skin examination device
AU6678894A (en) Diagnostic probes and their use in detecting human chromosomal abnormalities
AU9039691A (en) Rapid diagnostic device and kit
GB9010561D0 (en) Enzymes and their use in drug detection
NZ293526A (en) Cell abnormality and morphology detection in diagnosis
GB9126987D0 (en) Improvements in and relating to blood measurements
AP9500727A0 (en) 13-substituted milbemy in derivatives their preparation and use
AU2544292A (en) Improvements in oligonucleotide primers and probes
ZA943549B (en) Cell surface protein expressed on human cortical thymocyte and their use
AU6822796A (en) T-pa polymorphism and use thereof in diagnosis of risk of thrombus associated disease
AU6042994A (en) Apparatus for the collection and recovery of saliva for use in diagnostic assays
AU5447194A (en) Diagnostic reagents and their use in the detection of human herpesvirus 7
AU2546392A (en) Improvements in oligonucleotide primers and probes
AU5840794A (en) Improvements in or relating to testing apparatus and methods
HUP0001091A3 (en) New polyols and their use in polyurethanes preparation
NZ231429A (en) Diagnostic probes and their use in detecting mycobacterium paratuberculosis
AU7101696A (en) Diester and the use thereof as hydrophilising agent in pvc